PRICE T ROWE ASSOCIATES INC /MD/ - ENDOCYTE INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$57,931,000
+60.2%
3,261,891
+24.5%
0.01%
+33.3%
Q2 2018$36,153,000
+27.9%
2,619,809
-15.8%
0.01%
+50.0%
Q1 2018$28,268,000
+340.0%
3,109,800
+417.4%
0.00%
+300.0%
Q4 2013$6,424,000
+59.6%
601,000
+99.1%
0.00%0.0%
Q3 2013$4,024,000
-49.1%
301,900
-49.8%
0.00%0.0%
Q2 2013$7,900,000601,6000.00%
Other shareholders
ENDOCYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
RMB Capital Management, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders